News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
762,773 Results
Type
Article (47672)
Company Profile (337)
Press Release (714740)
Multimedia
Podcasts (161)
Webinars (25)
Section
Business (215263)
Career Advice (2312)
Deals (37601)
Drug Delivery (148)
Drug Development (85215)
Employer Resources (180)
FDA (17194)
Job Trends (15789)
News (365205)
Policy (35224)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2709)
Accelerated approval (43)
Adcomms (34)
Allergies (170)
Alliances (52704)
ALS (203)
Alzheimer's disease (1798)
Antibody-drug conjugate (ADC) (402)
Approvals (17475)
Artificial intelligence (642)
Autoimmune disease (235)
Automation (50)
Bankruptcy (382)
Best Places to Work (11888)
BIOSECURE Act (23)
Biosimilars (217)
Biotechnology (197)
Bladder cancer (179)
Brain cancer (67)
Breast cancer (702)
Cancer (5478)
Cardiovascular disease (479)
Career advice (1957)
Career pathing (45)
CAR-T (314)
CDC (63)
Celiac Disease (2)
Cell therapy (842)
Cervical cancer (41)
Clinical research (73165)
Collaboration (2007)
Company closure (6)
Compensation (1300)
Complete response letters (85)
COVID-19 (2876)
CRISPR (106)
C-suite (1028)
Cystic fibrosis (154)
Data (7144)
Decentralized trials (3)
Denatured (46)
Depression (162)
Dermatology (58)
Diabetes (572)
Diagnostics (6999)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (310)
Drug pricing (230)
Drug shortages (35)
Duchenne muscular dystrophy (278)
Earnings (94281)
Editorial (69)
Employer branding (21)
Employer resources (160)
Events (123680)
Executive appointments (1083)
FDA (20670)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1664)
Gene editing (225)
Generative AI (58)
Gene therapy (699)
GLP-1 (1145)
Government (5033)
Grass and pollen (7)
Guidances (398)
Healthcare (19451)
HIV (75)
Huntington's disease (54)
IgA nephropathy (95)
Immunology and inflammation (308)
Immuno-oncology (87)
Indications (158)
Infectious disease (3206)
Inflammatory bowel disease (213)
Inflation Reduction Act (14)
Influenza (130)
Intellectual property (281)
Interviews (365)
IPO (17207)
IRA (58)
Job creations (4224)
Job search strategy (1639)
JPM (71)
Kidney cancer (19)
Labor market (93)
Layoffs (618)
Leadership (42)
Legal (8742)
Liver cancer (101)
Longevity (29)
Lung cancer (736)
Lymphoma (413)
Machine learning (53)
Management (62)
Manufacturing (974)
MASH (190)
Medical device (14111)
Medtech (14190)
Mergers & acquisitions (21560)
Metabolic disorders (1536)
mRNA (192)
Multiple sclerosis (179)
NASH (22)
Neurodegenerative disease (407)
Neuropsychiatric disorders (109)
Neuroscience (3257)
Neurotech (1)
NextGen: Class of 2026 (6789)
Non-profit (4642)
Now hiring (73)
Obesity (750)
Opinion (328)
Ovarian cancer (188)
Pain (247)
Pancreatic cancer (259)
Parkinson's disease (353)
Partnered (34)
Patents (572)
Patient recruitment (604)
Peanut (64)
People (62424)
Pharmaceutical (95)
Pharmacy benefit managers (36)
Phase 1 (22816)
Phase 2 (32091)
Phase 3 (24071)
Pipeline (7222)
Policy (339)
Postmarket research (2730)
Preclinical (9633)
Press Release (68)
Prostate cancer (281)
Psychedelics (55)
Radiopharmaceuticals (317)
Rare diseases (1056)
Real estate (6528)
Recruiting (73)
Regulatory (26554)
Reports (54)
Research institute (2511)
Resumes & cover letters (384)
Rett syndrome (32)
RNA editing (19)
RSV (93)
Schizophrenia (176)
Series A (278)
Series B (209)
Service/supplier (14)
Sickle cell disease (110)
Special edition (28)
Spinal muscular atrophy (172)
Sponsored (47)
Startups (3883)
State (2)
Stomach cancer (20)
Supply chain (124)
Tariffs (101)
The Weekly (112)
Vaccines (1128)
Venture capital (105)
Weight loss (509)
Women's health (112)
Worklife (20)
Date
Last 7 days (654)
Last 30 days (2501)
Last 365 days (30910)
2026 (8257)
2025 (31256)
2024 (36343)
2023 (41159)
2022 (52387)
2021 (56922)
2020 (55451)
2019 (48182)
2018 (36451)
2017 (33932)
2016 (33632)
2015 (39468)
2014 (33429)
2013 (28591)
2012 (30666)
2011 (31335)
2010 (29332)
Location
Africa (851)
Alabama (91)
Alaska (7)
Arizona (343)
Arkansas (15)
Asia (45469)
Australia (7050)
California (12413)
Canada (3552)
China (1328)
Colorado (535)
Connecticut (531)
Delaware (374)
Europe (95299)
Florida (1885)
Georgia (397)
Hawaii (3)
Idaho (62)
Illinois (981)
India (85)
Indiana (575)
Iowa (22)
Japan (502)
Kansas (130)
Kentucky (44)
Louisiana (40)
Maine (73)
Maryland (1508)
Massachusetts (8943)
Michigan (350)
Minnesota (682)
Mississippi (6)
Missouri (138)
Montana (33)
Nebraska (29)
Nevada (139)
New Hampshire (83)
New Jersey (3334)
New Mexico (31)
New York (3281)
North Carolina (1638)
North Dakota (8)
Northern California (6117)
Ohio (376)
Oklahoma (23)
Oregon (47)
Pennsylvania (2511)
Puerto Rico (27)
Rhode Island (50)
South America (1228)
South Carolina (77)
South Dakota (1)
Southern California (4880)
Tennessee (202)
Texas (1956)
United States (44227)
Utah (373)
Vermont (1)
Virginia (309)
Washington D.C. (83)
Washington State (994)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
762,773 Results for "china pharma holdings inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
China
Lilly Pumps $3B Into China To Boost Supply of Weight Loss Pill
Orforglipron, Eli Lilly’s oral obesity drug, is under FDA review with a decision expected in April. The pharma has also filed for marketing authorization for the pill in China.
March 11, 2026
·
2 min read
·
Tristan Manalac
Funding
RA Capital Looks to China for Next Startup To Put on SPAC Track to Nasdaq
While RA Capital Management has yet to commit to a merger plan, it noted that its new blank-check company, Research Alliance III, could target companies abroad, including those from China.
March 25, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca
Like its pharma peers, Novartis is pouring money into Chinese operations, including expansions and upgrades at an existing manufacturing facility.
March 24, 2026
·
2 min read
·
Nick Paul Taylor
China
Clinical Trials Are Increasingly Going Global—With China a Main Beneficiary
AstraZeneca’s $15 billion pledge to its China operations highlights the country’s advantages. But other regions are also hoping to host more clinical studies.
February 2, 2026
·
8 min read
·
Annalee Armstrong
Insights
CRO Boom in APAC Region, With China at the Forefront
The CRO market in the APAC region is thriving, particularly in China, due to intense clinical trial and innovation development, with Western investors and pharma leaning in.
November 19, 2025
·
5 min read
·
Jennifer C. Smith-Parker
Press Releases
Ayrmid Appoints ACA Pharma as Exclusive Distributor for Omisirge(R) across Greater China and Southeast Asia
February 9, 2026
·
3 min read
Press Releases
Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288
February 6, 2026
·
8 min read
Weight loss
Regeneron’s Weight Loss Partner Hansoh Delivers Much-Needed Phase 3 Win in China
Hansoh’s olatorepatide achieved 19% weight loss at 48 weeks in a Phase 3 trial in China, handing partner Regeneron a glimmer of hope for a pipeline in desperate need of reinvigoration.
March 9, 2026
·
2 min read
·
Annalee Armstrong
Insights
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year of transformation and renewed momentum for life sciences.
November 12, 2025
·
5 min read
·
Jennifer C. Smith-Parker
Press Releases
Notice Of Annual General Meeting In Vicore Pharma Holding AB (PUBL)
April 1, 2026
·
34 min read
1 of 76,278
Next
